Literature DB >> 11693497

Secular trends in incidence and antimicrobial resistance among clinical isolates of Salmonella at a university hospital in Taiwan, 1983-1999.

L H Su1, C H Chiu, A J Kuo, J H Chia, C F Sun, H S Leu, T L Wu.   

Abstract

The incidence and antimicrobial resistance among clinical isolates of salmonella at a university hospital in Taiwan between 1983 and 1999 are summarized in this report. A total of 7986 isolates were analysed. Serogroup B has been the most prevalent over the years, with an apparently continuous decline after 1995. Concordant decrease was also found among S. choleraesuis and S. typhi isolates in recent years. In contrast, the proportion of serogroup D strains increased significantly after 1996. S. typhi remained relatively susceptible to most of the antimicrobial agents examined. For non-typhoidal isolates, antimicrobial resistance to ampicillin (62%), chloramphenicol (67%), and sulfamethoxazole-trimethoprim (37%) was relatively higher than that reported elsewhere. Newer generation cephalosporins and fluoroquinolones remained effective over the years, although emerging resistance to these drugs has been noticed since 1992. A more prudent selection and use of antimicrobial agents, in both humans and animals, and a continuous surveillance of resistance are essential in the future.

Entities:  

Mesh:

Year:  2001        PMID: 11693497      PMCID: PMC2869739          DOI: 10.1017/s0950268801005957

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  8 in total

1.  Prevalence and antimicrobial susceptibility of serogroup D nontyphoidal Salmonella in a university hospital in Taiwan.

Authors:  Cheng-Hsun Chiu; Lin-Hui Su; Ching-Chi Hung; Kuo-Lung Chen; Chishih Chu
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Ceftriaxone resistance of nontyphoidal Salmonella enterica isolates in Northern Taiwan attributable to production of CTX-M-14 and CMY-2 beta-lactamases.

Authors:  Wen-Chen Li; Fu-Yuan Huang; Chang-Pan Liu; Li-Chuan Weng; Nai-Yu Wang; Nan-Chang Chiu; Chuen-Sheue Chiang
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  In vitro and in vivo intracellular killing effects of tigecycline against clinical nontyphoid Salmonella isolates using ceftriaxone as a comparator.

Authors:  Hung-Jen Tang; Wen-Chien Ko; Chi-Chung Chen; Po-Lin Chen; Han Siong Toh; Tzu Chieh Weng; Wen-Liang Yu; Shyh-Ren Chiang; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

Review 4.  Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment.

Authors:  Cheng-Hsun Chiu; Lin-Hui Su; Chishih Chu
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

5.  Fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis, Taiwan, 2000-2003.

Authors:  Cheng-Hsun Chiu; Tsu-Lan Wu; Lin-Hui Su; Jien-Wei Liu; Chishih Chu
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

6.  Coptidis rhizome and Si Jun Zi Tang can prevent Salmonella enterica serovar Typhimurium infection in mice.

Authors:  Chiung-Hung Chang; Bi Yu; Chiu-Hsian Su; Daniel S Chen; Yu-Chi Hou; Yueh-Sheng Chen; Yuan-Man Hsu
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

7.  Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Sung-Pin Tseng; Chao-Fu Chang; Jen-Hsien Wan; Jing-Jou Yan; Chun-Ming Lee; Yin-Ching Chuang; Wen-Kuei Huang; Dine Yang; Jainn-Ming Shyr; Kwok-Woon Yu; Li-Shin Wang; Jang-Jih Lu; Wen-Chien Ko; Jiunn-Jong Wu; Feng-Yee Chang; Yi-Chueh Yang; Yeu-Jun Lau; Yung-Ching Liu; Cheng-Yi Liu; Shen-Wu Ho; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

8.  Current status of antimicrobial resistance in Taiwan.

Authors:  Po-Ren Hsueh; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.